DK165902C - Etoposid-praeparat - Google Patents

Etoposid-praeparat

Info

Publication number
DK165902C
DK165902C DK075886A DK75886A DK165902C DK 165902 C DK165902 C DK 165902C DK 075886 A DK075886 A DK 075886A DK 75886 A DK75886 A DK 75886A DK 165902 C DK165902 C DK 165902C
Authority
DK
Denmark
Prior art keywords
etoposide
preparation
etoposide preparation
Prior art date
Application number
DK075886A
Other languages
English (en)
Other versions
DK75886A (da
DK75886D0 (da
DK165902B (da
Inventor
Takashi Terada
Hideyuki Ishimado
Masaru Suzuki
Minoru Nakada
Gen Iti Idzu
Original Assignee
Nippon Kayaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Kk filed Critical Nippon Kayaku Kk
Publication of DK75886D0 publication Critical patent/DK75886D0/da
Publication of DK75886A publication Critical patent/DK75886A/da
Publication of DK165902B publication Critical patent/DK165902B/da
Application granted granted Critical
Publication of DK165902C publication Critical patent/DK165902C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK075886A 1985-02-19 1986-02-18 Etoposid-praeparat DK165902C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60031203A JPS61189230A (ja) 1985-02-19 1985-02-19 エトポシド製剤
JP3120385 1985-02-19

Publications (4)

Publication Number Publication Date
DK75886D0 DK75886D0 (da) 1986-02-18
DK75886A DK75886A (da) 1986-08-20
DK165902B DK165902B (da) 1993-02-08
DK165902C true DK165902C (da) 1993-06-28

Family

ID=12324856

Family Applications (1)

Application Number Title Priority Date Filing Date
DK075886A DK165902C (da) 1985-02-19 1986-02-18 Etoposid-praeparat

Country Status (10)

Country Link
US (1) US4734284A (da)
EP (1) EP0193287B1 (da)
JP (1) JPS61189230A (da)
KR (1) KR920003332B1 (da)
AU (1) AU583585B2 (da)
DE (1) DE3671372D1 (da)
DK (1) DK165902C (da)
ES (1) ES8704727A1 (da)
HU (1) HU196707B (da)
MX (1) MX9202976A (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US4772589A (en) * 1986-10-29 1988-09-20 Bristol-Myers Etoposide solution in NMP
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
CA2017916C (en) * 1989-06-07 1999-02-02 Minoru Aoki Etoposide preparations
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5468754A (en) * 1994-04-19 1995-11-21 Bionumerik Pharmaceuticals, Inc. 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
US5604233A (en) * 1994-04-28 1997-02-18 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US7258869B1 (en) * 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) * 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
NZ513441A (en) * 1999-02-08 2004-01-30 Alza Corp Stable non-aqueous single phase viscous drug delivery vehicles comprising a polymer a solvent and a surfactant
WO2001060353A1 (fr) * 2000-02-21 2001-08-23 Fujisawa Pharmaceutical Co., Ltd. Preparation liquide a absorbabilite amelioree
JP4995407B2 (ja) 2002-04-25 2012-08-08 バナー ファーマキャップス， インコーポレーテッド 咀嚼可能なソフトカプセル
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US20050220866A1 (en) * 2004-04-02 2005-10-06 Dr. Reddy's Laboratories Limited Novel capsule formulations of etoposide for oral use
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
ES2422864T3 (es) 2006-08-09 2013-09-16 Intarcia Therapeutics, Inc Sistemas de liberación osmótica y unidades de pistón
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
US8343140B2 (en) 2008-02-13 2013-01-01 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
EP3735944A1 (en) 2009-09-28 2020-11-11 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP4278996A3 (en) 2015-06-03 2024-01-24 i2o Therapeutics, Inc. Implant placement systems
AU2017268161B2 (en) 2016-05-16 2020-03-12 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CA3049034A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
EP3796890A1 (en) * 2017-12-28 2021-03-31 Ackler, Scott Formulations, systems, and methods for therapeutic treatment
WO2023220641A2 (en) 2022-05-11 2023-11-16 Juno Therapeutics, Inc. Methods and uses related to t cell therapy and production of same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH514578A (de) * 1968-02-27 1971-10-31 Sandoz Ag Verfahren zur Herstellung von Glucosiden
ZA728764B (en) * 1971-12-29 1973-08-29 Squibb & Sons Inc One piece gelatin capsules containing chloral hydrate
DE3200766A1 (de) * 1981-01-14 1982-09-16 Toyo Jozo Kk Praeparat mit ausgezeichneter absorptionseigenschaft
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
JPS6032799A (ja) * 1983-07-29 1985-02-19 Microbial Chem Res Found 新規４′−デメチル−４−エピポドフィロトキシン誘導体
NZ211078A (en) * 1984-03-19 1987-08-31 Bristol Myers Co Oral dosage form of etoposide
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
US4609644A (en) * 1984-06-15 1986-09-02 St. Jude Children's Research Hospital Epipodophyllotoxinquinone glucoside derivatives, method of production and use

Also Published As

Publication number Publication date
MX9202976A (es) 1992-07-01
EP0193287A3 (en) 1986-10-08
AU583585B2 (en) 1989-05-04
KR860006263A (ko) 1986-09-09
HU196707B (en) 1989-01-30
JPS6366810B2 (da) 1988-12-22
EP0193287B1 (en) 1990-05-23
HUT43953A (en) 1988-01-28
DK75886A (da) 1986-08-20
AU5279386A (en) 1986-08-28
KR920003332B1 (ko) 1992-04-27
DK75886D0 (da) 1986-02-18
US4734284A (en) 1988-03-29
ES8704727A1 (es) 1987-04-16
JPS61189230A (ja) 1986-08-22
DK165902B (da) 1993-02-08
EP0193287A2 (en) 1986-09-03
DE3671372D1 (de) 1990-06-28
ES552067A0 (es) 1987-04-16

Similar Documents

Publication Publication Date Title
DK165902C (da) Etoposid-praeparat
DK406586A (da) Erythromycinderivater
BR8600081A (pt) Conjunto de cabrestante
DK109886A (da) Erythromycinderivater
ATA155686A (de) Giesspfannenkopf
AT386920B (de) Maishaecksler
ATA122686A (de) Kettenschloss
ATA257585A (de) Ru-deruebungsgeraet
BR8501248A (pt) Sulcador pontiagudo
ATA173385A (de) Stiegenlift
ES284795Y (es) Estufa-quemador de gallinaza
RO93270A2 (ro) Burlan de tubare
KR880700208A (ko) 구조 부재
SE8504626D0 (sv) Centrallas
BR8500114A (pt) Conjunto de helice
SE8504591D0 (sv) Truga
BR6500257U (pt) Chaveiro-calendario-utilidades
BR6500852U (pt) Churrasqueira-espeto
BE903210A (fr) Gripneiges
BR6500027U (pt) Conzeiro
BR6500176U (pt) Pulverizador-cobridor
ATA8686A (de) Heukran
BR6500432U (pt) Polainas
BR6500481U (pt) Omeleteira
BR6500483U (pt) Dialisor

Legal Events

Date Code Title Description
PUP Patent expired